China Jo-Jo Drugstores, Inc. (CJJD)
NASDAQ: CJJD · Real-Time Price · USD
1.380
+0.030 (2.22%)
At close: Feb 21, 2025, 4:00 PM
1.360
-0.020 (-1.45%)
After-hours: Feb 21, 2025, 5:02 PM EST
China Jo-Jo Drugstores Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 147.13 | 154.54 | 148.81 | 164.39 | 133.13 | 117.33 | Upgrade
|
| Revenue Growth (YoY) | -4.87% | 3.85% | -9.48% | 23.48% | 13.47% | 9.09% | Upgrade
|
| Cost of Revenue | 117.35 | 123.43 | 114.53 | 127.87 | 103.89 | 91.8 | Upgrade
|
| Gross Profit | 29.77 | 31.11 | 34.28 | 36.52 | 29.24 | 25.53 | Upgrade
|
| Selling, General & Admin | 35.79 | 34.64 | 44.85 | 39.06 | 37.85 | 31.9 | Upgrade
|
| Operating Expenses | 35.79 | 34.64 | 55.21 | 39.06 | 37.85 | 31.9 | Upgrade
|
| Operating Income | -6.01 | -3.53 | -20.93 | -2.55 | -8.61 | -6.38 | Upgrade
|
| Interest Expense | -0.02 | -0.01 | -0.07 | -0.26 | -0.46 | -0.7 | Upgrade
|
| Interest & Investment Income | 0.5 | 0.52 | 0.88 | 0.4 | 0.71 | 1.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.06 | 0.47 | 1.68 | 0.46 | 0.24 | 0.2 | Upgrade
|
| EBT Excluding Unusual Items | -5.59 | -2.56 | -18.43 | -1.95 | -8.12 | -5.81 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.04 | -1.61 | -2.32 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | -0.15 | -0.23 | -0.63 | Upgrade
|
| Pretax Income | -5.55 | -4.17 | -20.74 | -2.1 | -8.34 | -6.44 | Upgrade
|
| Income Tax Expense | 0.03 | 0.06 | 0.39 | 1.1 | 0.03 | 0.02 | Upgrade
|
| Earnings From Continuing Operations | -5.59 | -4.23 | -21.14 | -3.2 | -8.38 | -6.46 | Upgrade
|
| Minority Interest in Earnings | 0 | 0 | 0 | 0.01 | 0.26 | 0.64 | Upgrade
|
| Net Income | -5.59 | -4.23 | -21.14 | -3.19 | -8.12 | -5.81 | Upgrade
|
| Net Income to Common | -5.59 | -4.23 | -21.14 | -3.19 | -8.12 | -5.81 | Upgrade
|
| Shares Outstanding (Basic) | 4 | 1 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 1 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 255.56% | 183.28% | 193.06% | 2.38% | 24.27% | 13.41% | Upgrade
|
| EPS (Basic) | -1.58 | -2.93 | -41.46 | -18.35 | -47.79 | -42.52 | Upgrade
|
| EPS (Diluted) | -1.58 | -2.93 | -41.46 | -18.35 | -47.80 | -43.20 | Upgrade
|
| Free Cash Flow | -14.94 | -4.01 | -3.58 | -5.69 | -0.57 | -8.32 | Upgrade
|
| Free Cash Flow Per Share | -4.23 | -2.78 | -7.03 | -32.68 | -3.35 | -60.85 | Upgrade
|
| Gross Margin | 20.24% | 20.13% | 23.04% | 22.21% | 21.97% | 21.76% | Upgrade
|
| Operating Margin | -4.09% | -2.29% | -14.06% | -1.55% | -6.47% | -5.43% | Upgrade
|
| Profit Margin | -3.80% | -2.74% | -14.20% | -1.94% | -6.10% | -4.95% | Upgrade
|
| Free Cash Flow Margin | -10.16% | -2.60% | -2.41% | -3.46% | -0.43% | -7.09% | Upgrade
|
| EBITDA | -5.06 | -2.76 | -20.23 | -1.29 | -6.86 | -4.32 | Upgrade
|
| EBITDA Margin | -3.44% | -1.79% | -13.59% | -0.78% | -5.15% | -3.68% | Upgrade
|
| D&A For EBITDA | 0.95 | 0.77 | 0.7 | 1.26 | 1.75 | 2.06 | Upgrade
|
| EBIT | -6.01 | -3.53 | -20.93 | -2.55 | -8.61 | -6.38 | Upgrade
|
| EBIT Margin | -4.09% | -2.29% | -14.06% | -1.55% | -6.47% | -5.43% | Upgrade
|
| Advertising Expenses | - | 0.3 | 0.49 | 0.36 | 0.31 | 0.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.